Intagras Posts Q2 Earnings Growth and the Addition of Six New Clients

Intagras is pleased to announce Q2 2009 earnings growth in addition to the signing of six new pharmaceutical clients during July. Chattem, DSE Healthcare Solutions, MedImmune, Numark Laboratories, WellSpring Pharmaceutical Corporation, and Prestige Brands, are the latest to choose the SPL Portal Web Service. They join an already impressive list of life science clients including Novartis, Merck, Amgen and many others. Like existing clients, they are taking advantage of the industry leadership position that Intagras has gained since the launch of SPL Portal.

Through industry groups, leadership teams, and intuitive design elements, Intagras management has successfully developed a unique solution to the FDA’s electronic Structured Product Labeling (SPL) requirements. SPL Portal, Intagras’ proprietary SaaS application specifically addresses the new electronic filing requirements from the FDA for Structured Product Labeling (SPL) within Pharmaceutical companies. SPL Portal clients benefit from a comprehensive service offering enabling them to navigate the complicated SPL labeling requirements set forth by the FDA.

“We are extremely pleased to welcome our new clients. This past quarter represented accelerated growth and expansion as clients chose us as their preferred vendor. As a result, our 2009 second quarter earnings increased significantly over Q2 2008 and Q1 2009. Intagras’ growth has remained strong in these challenging times because we retain and attract the best resources and insist on providing the highest level of quality to our clients. On behalf of every team member at Intagras, we sincerely look forward to servicing all of our new clients. ” said Craig Trautman , CEO of Intagras.